CONMED (NYSE: CNMD) is one of 53 public companies in the “Electromedical equipment” industry, but how does it contrast to its rivals? We will compare CONMED to similar businesses based on the strength of its risk, valuation, institutional ownership, profitability, dividends, earnings and analyst recommendations.

Insider and Institutional Ownership

46.7% of shares of all “Electromedical equipment” companies are owned by institutional investors. 5.4% of CONMED shares are owned by insiders. Comparatively, 16.3% of shares of all “Electromedical equipment” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares CONMED and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CONMED 0.05% 8.31% 3.31%
CONMED Competitors -269.42% -100.00% -22.66%

Volatility & Risk

CONMED has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, CONMED’s rivals have a beta of 0.80, meaning that their average share price is 20% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for CONMED and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED 0 0 0 0 N/A
CONMED Competitors 334 980 1673 86 2.49

As a group, “Electromedical equipment” companies have a potential upside of 8.06%. Given CONMED’s rivals higher probable upside, analysts plainly believe CONMED has less favorable growth aspects than its rivals.

Dividends

CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 0.9%. CONMED pays out 30.3% of its earnings in the form of a dividend. As a group, “Electromedical equipment” companies pay a dividend yield of 1.4% and pay out 39.7% of their earnings in the form of a dividend.

Valuation and Earnings

This table compares CONMED and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
CONMED $955.10 million $28.62 million 32.41
CONMED Competitors $1.11 billion $132.27 million 22.64

CONMED’s rivals have higher revenue and earnings than CONMED. CONMED is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

CONMED rivals beat CONMED on 7 of the 12 factors compared.

CONMED Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

Receive News & Ratings for CONMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED and related companies with MarketBeat.com's FREE daily email newsletter.